ACE2 as therapy for glomerular disease: the devil is in the detail

Kidney International

Volumn 91, Issue 6, 2017, Pages 1269-1271

  Ross, Michael J ^a   Nangaku, Masaomi ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; DIPEPTIDYL CARBOXYPEPTIDASE;

ACUTE KIDNEY FAILURE; ALBUMINURIA; ALPORT SYNDROME; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; GLOMERULOPATHY; HUMAN; HYPERTENSION; KIDNEY FIBROSIS; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; URETER OBSTRUCTION; ANIMAL; GLOMERULUS; MOUSE;

ANGIOTENSIN II; ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY GLOMERULUS; MICE; PEPTIDYL-DIPEPTIDASE A; PROTEINURIA;

EID: 85019112322     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2017.04.001     Document Type: Note

References (9)

1. Batlle, D., Wysocki, J., Soler, M.J., et al. Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy. Kidney Int 81 (2012), 520–528.
2. Oudit, G.Y., Liu, G.C., Zhong, J., et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59 (2010), 529–538.
3. Nadarajah, R., Milagres, R., Dilauro, M., et al. Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int 82 (2012), 292–303.
4. Ortiz-Melo, D.I., Gurley, S.B., Angiotensin converting enzyme 2 and the kidney. Curr Opin Nephrol Hypertens 25 (2016), 59–66.
5. Ye, M., Wysocki, J., Gonzalez-Pacheco, F.R., et al. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2. Hypertension 60 (2012), 730–740.
6. Liu, Z., Huang, X.R., Chen, H.Y., et al. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy. Lab Invest 92 (2012), 650–661.
7. Fang, F., Liu, G.C., Zhou, X., et al. Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury. PLoS One, 8, 2013, e71433.
8. Bae, E.H., Fang, F., Williams, V.R., et al. Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome. Kidney Int 91 (2017), 1347–1361.
9. Wysocki, J., Ye, M., Khattab, A.M., et al. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy. Kidney Int 91 (2017), 1336–1346.